Teva Pharmaceuticals USA, Inc

Complete recall history across all FDA and CPSC categories — 23 total recalls

Teva Pharmaceuticals USA, Inc appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.

Drug Recalls (23)

FDA drug safety enforcement actions by Teva Pharmaceuticals USA, Inc

Date Product Reason Class
Mar 17, 2026 Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, ... Lack of Assurance of Sterility: Quality system deficiencies identified during... Class II
Mar 17, 2026 Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, ... Lack of Assurance of Sterility: Quality system deficiencies identified during... Class II
Mar 17, 2026 Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, ... Lack of Assurance of Sterility: Quality system deficiencies identified during... Class II
Jan 29, 2026 Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets b... Failed Dissolution Specifications Class II
Jan 29, 2026 Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, R... Failed Dissolution Specifications Class II
Jan 29, 2026 Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (ND... Failed Dissolution Specifications Class II
Jan 29, 2026 Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (ND... Failed Dissolution Specifications Class II
Nov 7, 2025 Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dos... Defective Container - A defect in the side-seal which allows leakage of product. Class III
Oct 13, 2025 Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg... Subpotent drug; Clavulanate Potassium component Class II
Oct 7, 2025 Prazosin Hydrochloride, Capsules, USP, 5 mg, Rx only, Distributed by TEVA PHA... CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above... Class II
Oct 7, 2025 Prazosin Hydrochloride, Capsules, USP, 1 mg, Rx only, Distributed by TEVA PHA... CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above... Class II
Oct 7, 2025 Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHA... CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above... Class II
May 23, 2025 Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in... Presence of foreign tablets/capsules. Class II
Jan 10, 2025 Granix (tbo-filgrastim) Injection 300 mcg/0.5 mL, Single Dose prefilled syrin... Failed Stability Specifications - 12-month stability test result for one of t... Class II
Aug 8, 2024 Testosterone Gel, 1.62%, (Alcohol 80% v/v), 30 unit-dose packets, Rx Only, Te... Superpotent Drug Class II
Jun 28, 2024 Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 100 Tablets per bottle, ... Failed Impurities/Degradation Specifications: Product is being recalled due t... Class II
Jun 4, 2024 Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-co... Subpotent Drug Class II
Mar 28, 2024 Isotretinoin Capsules, USP 40mg, 30-count 3x10 blister packs per carton, Rx O... Superpotent Drug: The 3-month stability result for assay was found to be abov... Class II
Mar 7, 2024 Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic ... Failed Dissolution Specifications Class II
Jan 25, 2024 Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic reg... Discoloration: discolored tablets (shades of blue) mixed in with the white in... Class III
Jan 25, 2024 Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in... Discoloration: discolored tablets (shades of blue) mixed in with the white in... Class III
Jan 8, 2024 Budesonide Extended-Release Tablets 9mg, 30-count bottle, Rx Only, Manufactu... Failed Dissolution Specifications Class II
Nov 10, 2023 Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose pack... OOS for viscosity Class III

Frequently Asked Questions

A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.

Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.

The FDA classifies recalls into three categories. Class I is the most serious — there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious — the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.

Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.

Explore More Recalls

Search recalls by category, state, reason, or firm across all our databases.